Defective central nervous system dopaminergic function in rats with estrogen-induced pituitary tumors, as assessed by plasma prolactin concentrations.
D000818:Animals; D001921:Brain / Q000503:physiopathology*; D001971:Bromocriptine / Q000494:pharmacology; D004294:Domperidone / Q000494:pharmacology; D004298:Dopamine / Q000032:analysis; D004958:Estradiol / Q000031:analogs & derivatives; D005260:Female; D007031:Hypothalamus / Q000473:pathology; D008473:Median Eminence / Q000032:analysis; D009627:Nomifensine / Q000494:pharmacology; D010902:Pituitary Gland / Q000473:pathology; D010911:Pituitary Neoplasms / Q000139:chemically induced / Q000378:metabolism*; D011388:Prolactin / Q000097:blood*; D051381:Rats; D011919:Rats, Inbred Strains; D011954:Receptors, Dopamine / Q000502:physiology*; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology
D011954:Receptors, Dopamine; D009627:Nomifensine; D001971:Bromocriptine; D004958:Estradiol; D004294:Domperidone; D013973:Thyrotropin-Releasing Hormone; D011388:Prolactin; D004298:Dopamine